Adventia Pharma
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Effect of a Combined Exercise and Anti-Inflammatory Nutritional Intervention in Frail Older Adults
Role: collaborator
Analysis of the Aetiological Factors of Malnutrition
Role: collaborator
Study to Evaluate the Organoleptic Perception of Oral Nutritional Supplements for Oncological Patients
Role: collaborator
Efficacy of Two ONS in Patients at Nutritional Risk With Type 2 Diabetes Mellitus
Role: collaborator
Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition
Role: collaborator
Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease
Role: collaborator
All 6 trials loaded